22 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
and regulations regarding corporate governance practices. The listing requirements of the Nasdaq Global Market and the rules of the SEC require that we … satisfy certain corporate governance requirements relating to director independence, filing annual and interim reports, stockholder meetings, approvals
DRS
lx1vgzy1o
20 Oct 22
Draft registration statement
12:00am
DEF 14A
jcezfdq3v
25 Apr 22
Definitive proxy
5:28pm
10-K
lgskq8i xgp0
30 Mar 22
Annual report
7:40am
10-Q
6r02ail49b hb7o2wbo
17 Nov 21
Quarterly report
5:15pm
8-K
fiwcpyiunzjxw
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
8-K
EX-3.2
ts9y9 s6p
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
cgyplttql2
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
vj6ve9ks9ft2wy l24j
19 Jul 21
IPO registration
7:02am